Boston Scientific Statistics
Total Valuation
VIE:BSXC has a market cap or net worth of EUR 115.02 billion. The enterprise value is 124.33 billion.
| Market Cap | 115.02B |
| Enterprise Value | 124.33B |
Important Dates
The next estimated earnings date is Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.48B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.58% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 93.66% |
| Float | 1.48B |
Valuation Ratios
The trailing PE ratio is 46.60 and the forward PE ratio is 26.22.
| PE Ratio | 46.60 |
| Forward PE | 26.22 |
| PS Ratio | 6.73 |
| PB Ratio | 5.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 50.37 |
| EV / Sales | 7.32 |
| EV / EBITDA | 27.67 |
| EV / EBIT | 36.99 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.27 |
| Debt / FCF | n/a |
| Interest Coverage | 11.38 |
Financial Efficiency
Return on equity (ROE) is 12.68% and return on invested capital (ROIC) is 9.86%.
| Return on Equity (ROE) | 12.68% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.86% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 322,585 |
| Profits Per Employee | 46,570 |
| Employee Count | 53,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VIE:BSXC has paid 419.89 million in taxes.
| Income Tax | 419.89M |
| Effective Tax Rate | 14.56% |
Stock Price Statistics
The stock price has decreased by -22.20% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.20% |
| 50-Day Moving Average | 81.06 |
| 200-Day Moving Average | 86.75 |
| Relative Strength Index (RSI) | 21.89 |
| Average Volume (20 Days) | 678 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, VIE:BSXC had revenue of EUR 17.10 billion and earned 2.47 billion in profits. Earnings per share was 1.65.
| Revenue | 17.10B |
| Gross Profit | 11.76B |
| Operating Income | 3.38B |
| Pretax Income | 2.88B |
| Net Income | 2.47B |
| EBITDA | 4.52B |
| EBIT | 3.38B |
| Earnings Per Share (EPS) | 1.65 |
Balance Sheet
The company has 1.09 billion in cash and 10.26 billion in debt, with a net cash position of -9.17 billion.
| Cash & Cash Equivalents | 1.09B |
| Total Debt | 10.26B |
| Net Cash | -9.17B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 20.13B |
| Book Value Per Share | 13.44 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 68.78%, with operating and profit margins of 19.78% and 14.44%.
| Gross Margin | 68.78% |
| Operating Margin | 19.78% |
| Pretax Margin | 16.86% |
| Profit Margin | 14.44% |
| EBITDA Margin | 26.44% |
| EBIT Margin | 19.78% |
| FCF Margin | n/a |
Dividends & Yields
VIE:BSXC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.58% |
| Shareholder Yield | -0.58% |
| Earnings Yield | 2.15% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |